Oncogenic KRAS induces arginine auxotrophy and confers a therapeutic vulnerability to SLC7A1 inhibition in non-small cell lung cancer.
Gai X, Liu Y, Lan X, Chen L, Yuan T, Xu J, Li Y, Zheng Y, Yan Y, Yang L, Fu Y, Tang S, Cao S, Dai X, Zhu H, Geng M, Ding J, Pu C, Huang M.
Gai X, et al. Among authors: zheng y.
Cancer Res. 2024 Mar 19. doi: 10.1158/0008-5472.CAN-23-2095. Online ahead of print.
Cancer Res. 2024.
PMID: 38502865